National Institutes of Health: all 11,571 studies

Page 46 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Indenoisoquinoline LMP400 for Advanced Solid Tumors and LymphomasCompletedNCT01794104Phase 1
• Endometrial Cancer Testing With Vaginal and Endometrial Cell SamplesCompletedNCT01793545
• Study of [11C]DPA-713 for Temporal Lobe EpilepsyCompletedNCT01793532
• Transcranial Magnetic Stimulation for Focal Hand DystoniaTerminatedNCT01792336
• Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected AdultsCompletedNCT01783977Phase 1
• Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01783171Phase 1
• Validation of Gene Expression Markers of Renal Allograft Functional DeclineCompletedNCT01782586
• Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months ApartCompletedNCT01782300Phase 1
• Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of PrematurityCompletedNCT01780155
• Longitudinal Observational Study of Severe AsthmaCompletedNCT01780142
• Colon Cancer Study of Fecal Samples in Shanghai, ChinaCompletedNCT01778595
• Perspective-taking, and Examining the Clinical Trial Informed Consent ProcessCompletedNCT01778582
• The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)CompletedNCT01778569
• Treatment of Functional Movement Disorders With PsychotherapyCompletedNCT01778517Not applicable
• Studying Childhood-onset Behavioral, Psychiatric, and Developmental DisordersCompletedNCT01778504
• AMD Phenotype and Genotype StudyCompletedNCT01778491
• A Pilot Study to Extend the K-SADS-PL to Adolescents and Young AdultsCompletedNCT01778478
• 18F-CP18 Imaging Studies for Cancer Treatment With BirinapantWithdrawnNCT01766622Phase 2
• Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid LeukemiaCompletedNCT01757639Phase 1
• LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE VaccineCompletedNCT01751048Phase 1
• Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT01749397Phase 1
• Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT01749384Phase 1
• Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)TerminatedNCT01748812Phase 1
• Bisnorcymserine in Healthy Adult VolunteersCompletedNCT01747213Phase 1
• Effects of Transcranial Magnetic Stimulation on Object RecognitionCompletedNCT01747200Not applicable
• Testing the AVI-7100 Flu Drug in Healthy VolunteersCompletedNCT01747148Phase 1
• Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly PopulationsCompletedNCT01746082Phase 2
• RELIVE Informed Consent StudyCompletedNCT01742234
• Living With Frontotemporal DementiaTerminatedNCT01738386
• Factors Affecting Methamphetamine and Opiates Drug TestingCompletedNCT01736332Phase 1
• Artemisinin-resistant Malaria in CambodiaCompletedNCT01736319
• Biomarkers for Breast Cancer Risk in African American WomenCompletedNCT01736306
• Natural History of Eye Diseases Related to ABCA4 MutationsActive, not recruitingNCT01736293
• Evaluating and Treating Potential Research Participants With Digestive DisordersTerminatedNCT01736280Not applicable
• Environmental Risk Factors for Myositis in Military PersonnelCompletedNCT01734369
• Studying Cell Immune Responses to a Live Flu Vaccine in Healthy AdultsCompletedNCT01730144
• Chronic Cold Exposure and Energy Metabolism in HumansCompletedNCT01730105
• Near Infrared Spectroscopy in Children With Autism and ADHDTerminatedNCT01730079
• Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell LymphomaCompletedNCT01729806Phase 1
• Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerCompletedNCT01727076Phase 1
• Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid TumorsCompletedNCT01725191Phase 1
• Genetic, Brain Structure, and Environmental Effects on ADHDCompletedNCT01721720
• Omalizumab for LupusCompletedNCT01716312Phase 1
• Genomics of Kidney TransplantationCompletedNCT01714440
• Bacterial Arrangement on the TeethCompletedNCT01712672
• Daily Intranasal Oxytocin for Childhood-Onset SchizophreniaTerminatedNCT01712646Phase 1/2
• Tests of Functional Magnetic Resonance Imaging TechniquesTerminatedNCT01712633
• Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent NeuroblastomaActive, not recruitingNCT01711554Phase 1
• Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaCompletedNCT01711528Phase 1
• Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical CancerCompletedNCT01711515Phase 1
• Individual and Group Intervention Formats With Aggressive ChildrenCompletedNCT01710969Not applicable
• Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIVStatus unknownNCT01709448
• Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By SurgeryTerminatedNCT01705340Phase 1
• Studying Nicotine Addiction With Transcranial Magnetic StimulationCompletedNCT01702948
• Ovarian Stem Cells From Women With Ovarian InsufficiencyCompletedNCT01702935
• Relationship Stressors in Parents of Children With Cancer or Neurofibromatosis Type 1 (NF1)CompletedNCT01702922
• Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLEWithdrawnNCT01702038Phase 2
• Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin LymphomaActive, not recruitingNCT01695941Phase 1
• Brain Imaging for HIV-Associated Thinking and Mood DisordersTerminatedNCT01692236
• Environmental Polymorphisms Registry Health and Exposures SurveyCompletedNCT01688986
• GRN1005 for Brain Metastases From Breast or Lung CancerWithdrawnNCT01679743Phase 2
• Understanding Drug Abuse Treatment OutcomesCompletedNCT01678833
• The COX-2 Gene and the Immune SystemCompletedNCT01678222
• Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 YearsCompletedNCT01676402Phase 1
• Intravitreal Injections of Sirolimus in the Treatment of Geographic AtrophyTerminatedNCT01675947Phase 2
• Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy VolunteersCompletedNCT01674218Phase 1
• Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus VaccinesCompletedNCT01674205Phase 1
• Fluorodeoxyglucose Imaging Studies to Detect LymphomaWithdrawnNCT01672918
• Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant RecipientsCompletedNCT01672164
• Self-Affirmation and Response to Health Risk InformationCompletedNCT01668771
• fMRI and NIRS Imaging for Traumatic Brain InjuryWithdrawnNCT01668758
• Brain P-gp and Inflammation in People With EpilepsyCompletedNCT01663545
• Testing the FLASHE SurveyCompletedNCT01661036
• The Ghana Breast Health StudyCompletedNCT01661023
• The Clinical Study of Sex Chromosome VariantsCompletedNCT01661010
• MLN9708 and Dexamethasone for High-Risk Smoldering Multiple MyelomaWithdrawnNCT01660997Phase 2
• Natural History Study of Children and Adults With Medullary Thyroid CancerActive, not recruitingNCT01660984
• Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by SurgeryActive, not recruitingNCT01660971Phase 1
• Collecting Solid Tumor Tissue to Identify New TreatmentsCompletedNCT01658917
• Pexacerfont for Stress-induced Food CravingTerminatedNCT01656577Early Phase 1
• Clinical Outcomes of People Who Acquired HIV in Early LifeCompletedNCT01656564
• Randomized Trial of Home Versus Clinic-Based STD TestingCompletedNCT01654991Not applicable
• Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT01654965Phase 1
• Influenza Antiviral DAS-181-F04 in Healthy AdultsCompletedNCT01651494Phase 1
• Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib MaintenanceWithdrawnNCT01647165Phase 2
• Ustekinumab for Active Sight-Threatening UveitisWithdrawnNCT01647152Phase 1/2
• Uncertain Genetic Test Results for Lynch SyndromeCompletedNCT01646112
• Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are MetastaticCompletedNCT01643278Phase 1
• Validating Pain Scales in Children and Young AdultsCompletedNCT01639950
• Myocardial Perfusion and Scarring in Congenital Heart DiseaseTerminatedNCT01639937
• Evaluation of People With Gastrointestinal DiseaseCompletedNCT01639924
• Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
• Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)CompletedNCT01634750Phase 1
• Estimating Brain Biomechanics Using MRICompletedNCT01633268
• [18]F-Fluciclatide for Kidney Cancer Imaging Studies and TreatmentWithdrawnNCT01633255Phase 1/2
• Heart Imaging in Children With Muscular DystrophyTerminatedNCT01633242
• Bone Marrow Stromal Cell Infusions for Stem Cell Transplant ComplicationsCompletedNCT01633229Phase 1
• Developing the Family Map: Looking at Communal CopingCompletedNCT01633021
• Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic PainCompletedNCT01633008Early Phase 1
• Genetic Studies of Non-Alcoholic Fatty Liver DiseaseTerminatedNCT01629095

← National Institutes of Health overview and focus areas